Skip to contentS
Syra Health Corp
S
SYRASyra Health Corp Q1 2026 · 10-Q
Revenue$2.27M$2.27M+22.4% vs Q1 2025 Net Income$240.98K$240.98KN/M vs Q1 2025 EPS Diluted$0.02$0.02N/M vs Q1 2025 Gross Profit$971,255+64.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Syra Health Corp · CIK 1922335 · Engraved from SEC EDGAR
Operating Cash Flow$1,361,945+760.7% Margins · derivedGross margin42.7%+11.0 pt vs Q1 2025
Operating margin8.4%+33.9 pt vs Q1 2025
Net margin10.6%+36.0 pt vs Q1 2025
ended Mar 31, 2026 · filed May 7, 2026 · 37 d after period end